Ustekinumab: Injection 45 mg in 0.5 mL, Injection 45 mg in 0.5 mL single use pre filled syringe, Injection 90 mg in 1 mL single use pre filled syringe, Solution for I.V. infusion 130 mg in 26 mL; Wezlana^®

Page last updated: 5 July 2024

• Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 570KB)
• Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 100KB)